The advance has the potential to eliminate complications that arise from missing doses of life-saving medicines, according to the study published today in Nature Materials, a leading peer-reviewed biomedical research journal.
The Jan. 17 issue of the Journal of the American Medical Association (JAMA) features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert. The study and editorial sets the record straight on an unproven therapy some physicians use to treat sepsis, a deadly infectious disease.
The editorial, written by Andre Kalil, M.D., M.P.H., professor of infectious diseases in the UNMC Department of Internal Medicine, writes in support of the new and rigorous international study based on a randomized clinical trial in Australia, published in the same issue. The editorial appears in the Jan. 17 online issue and also will appear in the Feb. 4 print edition.
A study published today online in the Journal of the American Medical Association (JAMA) found marijuana use in electronic cigarettes has been increasing among U.S. middle and high school students from 2017 to 2018.
Evaluation shows gene editing has become 10 to 20 times more efficient in past six years in generating complex animal models called conditional knockouts, which ultimately provide greater insight into gene function and disease findings.
UNMC is the only institution in the central plains region participating in the research. Globally, 880 patients will be enrolled at 130 sites in 20 countries. Researchers will follow patients for up to five years.
Courtney Burnette, Ph.D., an international expert in the diagnosis of children with autism spectrum disorders and the early identification of young children at risk for this diagnosis, has been named the director of the Munroe-Meyer Institute’s integrated Center for Autism Spectrum Disorders (iCASD).
There are plenty of evidence-based behavioral health programs aimed at helping children and adolescents, but implementing those programs can often take up to three years and sustaining them can be even more difficult once implemented.
University of Nebraska Medical Center leading national team to determine if ruxolitinib is effective for treating a certain type of graft versus host disease (GVHD) called sclerotic. The grant is funded by Incyte, a global biopharmaceutical company.
A study published this month in the Annals of Internal Medicine found that adults with severe obesity had greater initial and sustained weight loss with gastric bypass surgery compared to sleeve gastrectomy or adjustable gastric banding surgery.